Clinical Genomics Uppsala is jointly set up by Uppsala University, Uppsala University Hospital and SciLifeLab with the aim to catalyze the transition of novel research findings into molecular diagnostics for clinical use. The facility is fully integrated within the Uppsala University Hospital and has extensive experience in development and implementation of state-of-the-art next-generation sequencing (NGS) technology in routine diagnostics. The facility takes on research and development projects with a clear translational profile. With our team of facility associated geneticists, bioinformaticians and medical doctors, we can deliver clinical assessments of the detected variants with the aim to truly provide bench-to-bedside service.
Clinical Genomics Uppsala provides services within next generation sequencing (NGS) and other molecular technologies. We take on projects that include development of methods for clinical implementation or translational research with strong clinical utility.
Current focus areas are solid tumors, hematological malignancies and inherited diseases.
If you are interested in more information, please contact Malin Melin or Eva Berglund.
751 85 Uppsala
Visitor address / Deliveries
Dag Hammarskjölds väg 20,
751 85 Uppsala
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.